Home > Cashflow Statement > MARKSANS PHARMA

MARKSANS PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

MARKSANS PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-65 Cr₹-69 Cr₹198 Cr₹80 Cr₹-15 Cr

What is the latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA ?

The latest Cash Flow from Financing Activities ratio of MARKSANS PHARMA is ₹-65 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-65 Cr
Mar2024₹-69 Cr
Mar2023₹198 Cr
Mar2022₹80 Cr
Mar2021₹-15 Cr

How is Cash Flow from Financing Activities of MARKSANS PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-65 Cr
Negative
Mar2024 ₹-69 Cr
Negative
Mar2023 ₹198 Cr
148.81
Mar2022 ₹80 Cr
Positive
Mar2021 ₹-15 Cr -

Compare Cash Flow from Financing Activities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹8,089.6 Cr -4.5% 3.6% -32.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.5%

3.6%

-32.1%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses